Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Pharmaceutics

• Publication date

  2009-07-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/mp900107vPMID 19606864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.

  2009cited by this paper
• In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery using an optimized radiolabeling and purification procedure.

  2009cited by this paper
• Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice.

  2009cited by this paper
• Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug

  2009cited by this paper
• Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging.

  2009cited by this paper
• Extracellular barriers to in Vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver.

  2008cited by this paper
• Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides

  2008cited by this paper
• Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro.

  2008cited by this paper
• Oral instillation with surfactant phospholipid: a reliable alternative to intratracheal injection in mouse studies

  2008cited by this paper
• Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo.

  2008cited by this paper
• In vivo animal models for drug delivery across the lung mucosal barrier.

  2007cited by this paper
• Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs.

  2007cited by this paper
• Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability.

  2006cited by this paper
• Physiochemical properties of low and high molecular weight poly(ethylene glycol)-grafted poly(ethylene imine) copolymers and their complexes with oligonucleotides.

  2006cited by this paper
• The silent treatment: siRNAs as small molecule drugs

  2006cited by this paper
• Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.

  2006cited by this paper
• In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice.

  2005cited by this paper
• Functional polarity is introduced by Dicer processing of short substrate RNAs

  2005cited by this paper
• Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy

  2005cited by this paper
• In vivo gene silencing (with siRNA) of pulmonary expression of MIP‐2 versus KC results in divergent effects on hemorrhage‐induced, neutrophil‐mediated septic acute lung injury

  2005cited by this paper
• Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

  2005cited by this paper
• Inhibition of respiratory viruses by nasally administered siRNA

  2005cited by this paper
• Critical period for alveologenesis and early determinants of adult pulmonary disease.

  2004cited by this paper
• Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants.

  2004cited by this paper
• RNA interference and chemically modified small interfering RNAs.

  2004cited by this paper
• Protection against lethal influenza virus challenge by RNA interference in vivo.

  2004cited by this paper
• Small Interfering RNA Targeting Heme Oxygenase-1 Enhances Ischemia-Reperfusion-induced Lung Apoptosis*

  2004cited by this paper
• Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles.

  2003cited by this paper
• EXTRAPULMONARY TRANSLOCATION OF ULTRAFINE CARBON PARTICLES FOLLOWING WHOLE-BODY INHALATION EXPOSURE OF RATS

  2002cited by this paper
• Physiology of airway mucus clearance.

  2002cited by this paper
• Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries

  2002cited by this paper
• Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats.

  2001cited by this paper
• Pulmonary cytokine responses associated with PEI–DNA aerosol gene therapy

  2001cited by this paper
• Interactions Between Oligonucleotides and Cationic Polymers Investigated by fluorescence Correlation Spectroscopy

  2001cited by this paper
• Argonaute2, a Link Between Genetic and Biochemical Analyses of RNAi

  2001cited by this paper
• Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster.

  2001cited by this paper
• Long-circulating vectors for the systemic delivery of genes.

  2001cited by this paper
• Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes.

  1998cited by this paper
• Various immunological phenotypes are associated with increased airway responsiveness

  1998cited by this paper
• Tc‐99m MAA Lung Perfusion Scintigraphy Performed Before and After Pulmonary Embolectomy for Saddle‐Type Pulmonary Embolism

  1995cited by this paper
• Circular dichroism.

  1995cited by this paper
• Interaction of polycations with cell-surface negative charges of epithelial cells.

  1992cited by this paper
• Effect of lung airway branching pattern and gas composition on particle deposition. II. Experimental studies in human and canine lungs.

  1988cited by this paper
• Synthesis and hybridization studies on two complementary nona(2'-O-methyl)ribonucleotides.

  1987cited by this paper
• Study of the circular dichroism of bacteriophage phi 6 and phi 6 nucleocapsid.

  1986cited by this paper
• Influence of airway and airspace sizes on particle deposition in excised donkey lungs.

  1985cited by this paper
• Spermine and spermidine-induced B to A transition of DNA in solution.

  1979cited by this paper
• A comparative X-ray diffraction and circular dichroism study of DNA compact particles formed in water-salt solutions, containing poly(ethylene glycol).

  1976cited by this paper

• Small Interfering RNA Carriers for Oncotherapy: A Preclinical Overview

  2025cites this paper
• Machine Learning‐Enabled Polymer Discovery for Enhanced Pulmonary siRNA Delivery

  2025cites this paper
• One-pot modular nanogel platform utilizing phenolic gelatin-polyethyleneimine for small RNA delivery

  2025cites this paper
• Exploring modified chitosan-based gene delivery technologies for therapeutic advancements.

  2024cites this paper
• Liposomal Nanoformulation-encapsulated Paclitaxel for Reducing Chemotherapy Side Effects in Lung Cancer Treatments: Recent Advances and Future Outlooks.

  2024cites this paper
• Closing the Gap between Experiment and Simulation—A Holistic Study on the Complexation of Small Interfering RNAs with Polyethylenimine

  2024cites this paper
• A facile and scalable method to synthesize PEGylated PDMAEMA for gene delivery

  2024cites this paper
• A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines.

  2024cites this paper
• Shielding siRNA by peptide-based nanofibers: An efficient approach for turning off EGFR gene in breast cancer.

  2024cites this paper
• Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome.

  2023cites this paper
• Delivery of nucleic acids using nanomaterials

  2023cites this paper
• Pulmonary siRNA Delivery with Sophisticated Amphiphilic Poly(Spermine Acrylamides) for the Treatment of Lung Fibrosis

  2023cites this paper
• Recent Advances in Engineering Carriers for siRNA Delivery.

  2023cites this paper
• Modification of Branched poly(Ethylene Imine) with d-Fructose for Selective Delivery of siRNA into Human Breast Cancer Cells.

  2023cites this paper
• Pulmonary Delivery for miRs: Present and Future Potential

  2023cites this paper
• Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery

  2022cites this paper
• Comparison of tyrosine-modified low molecular weight branched and linear polyethylenimines for siRNA delivery

  2022cites this paper
• siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review

  2022cites this paper
• Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy

  2022cites this paper
• Can pulmonary RNA delivery improve our pandemic preparedness?

  2022cites this paper
• Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes

  2022cites this paper
• Transposition of polymer-encapsulated small interfering RNA through lung surfactant models at the air-water interface

  2022cites this paper
• The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19?

  2021cites this paper
• Engineering Gene Therapy: Advances and Barriers

  2021cites this paper
• Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs

  2021cites this paper
• Optimization of PEGylated KL4 Peptide for siRNA Delivery with Improved Pulmonary Tolerance.

  2021cites this paper
• Poly(lactide-co-glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after Pulmonary Administration.

  2021cites this paper
• Chitosan oligosaccharide modified liposomes enhance lung cancer delivery of paclitaxel

  2021cites this paper
• siRNA Therapeutics against Respiratory Viral Infections—What Have We Learned for Potential COVID‐19 Therapies?

  2021cites this paper
• Polymeric Delivery of Therapeutic Nucleic Acids.

  2021cites this paper
• Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread

  2021cites this paper
• The mixture of siRNAs targeted to IL-4 and IL-13 genes effectively reduces the airway hyperreactivity and allergic inflammation in a mouse model of asthma.

  2021cites this paper
• Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules

  2021cites this paper
• Nanoparticles for local delivery of siRNA in lung therapy.

  2021cites this paper
• Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy

  2020cites this paper
• Combined Chemisorption and Complexation Generate siRNA Nanocarriers with Biophysics Optimized for Efficient Gene Knockdown and Air–Blood Barrier Crossing

  2020cites this paper
• Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges.

  2020cites this paper
• Degradable double hydrophilic block copolymers and tripartite polyionic complex micelles thereof for small interfering ribonucleic acids (siRNA) delivery.

  2020cites this paper
• In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8/CxCL-1 siRNA Delivery to the Lungs

  2020cites this paper
• Engineered polymeric nanovehicles for drug delivery

  2020cites this paper
• Nanomaterials-Based siRNA Delivery: Routes of Administration, Hurdles and Role of Nanocarriers

  2019cites this paper
• Nanotechnology in Modern Animal Biotechnology

  2019cites this paper
• Biodegradable Polymers as a Noncoding miRNA Nanocarrier for Multiple Targeting Therapy of Human Hepatocellular Carcinoma

  2019cites this paper
• Flow Cytometry-Based Cell Type-Specific Assessment of Target Regulation by Pulmonary siRNA Delivery.

  2019cites this paper
• Advances in Chitin/Chitosan Characterization and Applications

  2019influential citation
• Intrapulmonary Cellular-Level Distribution of Inhaled Nanoparticles with Defined Functional Groups and Its Correlations with Protein Corona and Inflammatory Response.

  2019cites this paper
• PolymericsiRNA gene delivery- transfection efficiency versus cytotoxicity.

  2019cites this paper
• Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.

  2019cites this paper
• Development of a cationic polymer-based siRNA delivery system for the regeneration of tendon injury

  2019cites this paper
• Nanocarriers in effective pulmonary delivery of siRNA: current approaches and challenges.

  2019cites this paper
• Coming in and Finding Out: Blending Receptor‐Targeted Delivery and Efficient Endosomal Escape in a Novel Bio‐Responsive siRNA Delivery System for Gene Knockdown in Pulmonary T Cells

  2019cites this paper
• Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs

  2018cites this paper
• RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers

  2018cites this paper
• Formulation of RNA interference-based drugs for pulmonary delivery: challenges and opportunities.

  2018cites this paper
• siRNA delivery for treatment of degenerative diseases, new hopes and challenges

  2018cites this paper
• Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer model.

  2018cites this paper
• Graphene oxide size and oxidation degree govern its supramolecular interactions with siRNA.

  2018cites this paper
• Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles

  2018cites this paper
• Corneal chemical burn treatment through a delivery system consisting of TGF-β1 siRNA: in vitro and in vivo

  2018cites this paper
• Chitosan in Non-Viral Gene Delivery: Role of Structure, Characterization Methods, and Insights in Cancer and Rare Diseases Therapies

  2018cites this paper
• Fluorescence- and computed tomography for assessing the biodistribution of siRNA after intratracheal application in mice.

  2017cites this paper
• Interfacial analysis of siRNA complexes with poly-ethylenimine (PEI) or PAMAM dendrimers in gene delivery.

  2017cites this paper
• Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens

  2017cites this paper
• Improved siRNA delivery efficiency via solvent-induced condensation of micellar nanoparticles

  2017cites this paper
• EFFECTS OF CORE AND SHELL MODIFICATION TO TETHERED NANOASSEMBLIES ON SIRNA THERAPY

  2017cites this paper
• Self‐aggregating 1.8 kDa polyethylenimines with dissolution switch at endosomal acidic pH are delivery carriers for plasmid DNA, mRNA, siRNA and exon‐skipping oligonucleotides

  2017cites this paper
• Enhanced Polyethylenimine‐Based Delivery of Nucleic Acids

  2017cites this paper
• Tunable PEGylation of branch-type PEI/DNA polyplexes with a compromise of low cytotoxicity and high transgene expression: in vitro and in vivo gene delivery.

  2017cites this paper
• Polymeric Scaffold Based Gene Delivery Strategies to Improve Angiogenesis in Tissue Engineering: A Review

  2017cites this paper
• Recent advances of biomaterials in biotherapy

  2016cites this paper
• From Genesis to Revelation: The Role of Inflammatory Mediators in Chronic Respiratory Diseases and their Control by Nucleic Acid-based Drugs.

  2016cites this paper
• Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines.

  2016cites this paper
• Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma.

  2016cites this paper
• Polyethylenimine: A versatile, multifunctional non-viral vector for nucleic acid delivery.

  2016cites this paper
• Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.

  2016cites this paper
• Targeting HPV‐infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine

  2016cites this paper
• Applicability of avidin protein coated mesoporous silica nanoparticles as drug carriers in the lung.

  2016cites this paper
• Insight into the relationship between the cell culture model, cell trafficking and siRNA silencing efficiency

  2016cites this paper
• Fine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivity.

  2016cites this paper
• Insight of In Vitro Small-Interfering RNA Release From Chitosan Nanoparticles Under Enzymolysis With Förster Resonance Energy Transfer Analysis.

  2016cites this paper
• Biokinetic studies of non-complexed siRNA versus nano-sized PEI F25-LMW/siRNA polyplexes following intratracheal instillation into mice.

  2016cites this paper
• Non-viral gene therapy: Gains and challenges of non-invasive administration methods.

  2016cites this paper
• Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.

  2016cites this paper
• ε-Caprolactone-Modified Polyethylenimine as Efficient Nanocarriers for siRNA Delivery in Vivo.

  2016cites this paper
• Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.

  2016cites this paper
• The synthesis and comparison of chondroitin sulfate-modified PDMAEMA with chondroitin sulfate-modified PEI as a potential gene delivery vector

  2016cites this paper
• Nanoparticle delivery systems for siRNA-based therapeutics.

  2016cites this paper
• Vectorisation de petits acides nucléiques par des lipopolyplexes : application au cancer du sein

  2016cites this paper
• Chitosan Nanoplexes For Target siRNA Delivery

  2016cites this paper
• Delivering Nucleic‐Acid Based Nanomedicines on Biomaterial Scaffolds for Orthopedic Tissue Repair: Challenges, Progress and Future Perspectives

  2016cites this paper
• Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).

  2016cites this paper
• Nanotechnology in Gene Knockdown and miRNA Replacement In Vivo

  2016cites this paper
• Exploring Critical Vehicle Parameters for the Design of Multitargeted Nanoparticles for Cancer Specific Gene Delivery

  2015cites this paper
• Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation.

  2015cites this paper
• Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.

  2015cites this paper
• Dry Powder Inhalation for Pulmonary Delivery: Recent Advances and Continuing Challenges

  2015cites this paper
• Histological Quantification of Gene Silencing by Intratracheal Administration of Dry Powdered Small-Interfering RNA/Chitosan Complexes in the Murine Lung

  2015cites this paper
• Dendrimer nanoconjugates and their oral inhalation formulations for lung cancer therapy

  2015cites this paper
• Modified Poly(lactic‐co‐glycolic Acid) Nanoparticles for Enhanced Cellular Uptake and Gene Editing in the Lung

  2015cites this paper
• Formulation strategies and particle engineering technologies for pulmonary delivery of biopharmaceuticals.

  2015cites this paper